CV Sciences (CVSI) Asset Writedowns and Impairment (2013 - 2020)

CV Sciences has disclosed Asset Writedowns and Impairment across 7 years of filings, most recently posting $6.2 million for Q4 2020.

• Asset Writedowns and Impairment for Q4 2020 came in at $6.2 million, up 3031.31% year-over-year; the trailing twelve-month figure through Dec 2020 was $6.4 million (up 2613.56% YoY), and the FY2023 annual result was $251000.0, down 79.66% from the prior year.
• Asset Writedowns and Impairment came in at $6.2 million for Q4 2020 at CV Sciences, up from $198000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $6.2 million in Q4 2020 to a low of -$1000.0 in Q2 2018.
• The 5-year median for Asset Writedowns and Impairment is $32000.0 (2019), against an average of $635838.7.
• Across the five-year window, Asset Writedowns and Impairment sank 100.25% in 2018 and surged 9800.0% in 2019, its largest moves.
• CV Sciences' Asset Writedowns and Impairment stood at $31003.0 in 2016, then surged by 166.31% to $82565.0 in 2017, then tumbled by 97.58% to $2000.0 in 2018, then soared by 9800.0% to $198000.0 in 2019, then jumped by 3031.31% to $6.2 million in 2020.
• The last three Asset Writedowns and Impairment figures came in at $6.2 million (Q4 2020), $198000.0 (Q4 2019), and $6000.0 (Q3 2019), per Business Quant data.